Literature DB >> 26667974

Chemotherapy: NAPOLI-1: winning scoop for metastatic pancreatic cancer.

Lisa Hutchinson.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 26667974     DOI: 10.1038/nrclinonc.2015.220

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN: 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial.

Authors:  Andrea Wang-Gillam; Chung-Pin Li; György Bodoky; Andrew Dean; Yan-Shen Shan; Gayle Jameson; Teresa Macarulla; Kyung-Hun Lee; David Cunningham; Jean F Blanc; Richard A Hubner; Chang-Fang Chiu; Gilberto Schwartsmann; Jens T Siveke; Fadi Braiteh; Victor Moyo; Bruce Belanger; Navreet Dhindsa; Eliel Bayever; Daniel D Von Hoff; Li-Tzong Chen
Journal:  Lancet       Date:  2015-11-29       Impact factor: 79.321

  1 in total
  1 in total

1.  Clinical trials: New drug for pancreatic cancer highlights the dual effect of regulatory approvals.

Authors:  Susan E Bates; Tito Fojo
Journal:  Nat Rev Clin Oncol       Date:  2016-02-23       Impact factor: 66.675

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.